SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-24-097951
Filing Date
2024-04-16
Accepted
2024-04-16 17:27:57
Documents
3
Period of Report
2024-06-27

Document Format Files

Seq Description Document Type Size
1 PRE 14A d874273dpre14a.htm PRE 14A 587167
2 GRAPHIC g874273g03g03.jpg GRAPHIC 352557
3 GRAPHIC g874273g04g04.jpg GRAPHIC 222056
  Complete submission text file 0001193125-24-097951.txt   1379825
Mailing Address ONE CORPORATE DR., 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address ONE CORPORATE DR., 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (800) 466-6059
Aligos Therapeutics, Inc. (Filer) CIK: 0001799448 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-39617 | Film No.: 24848803
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)